Isothermal Nucleic Acid Amplification Technology Market - 2024-2031

December 2024 | 74 pages | ID: I20D501B84C3EN
DataM Intelligence

US$ 3,400.00 US$ 4,350.00 -22 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Isothermal Nucleic Acid Amplification Technology Marketis is growing with a CAGR of 11.10% during the forecast period 2026-2035.

The Isothermal Nucleic Acid Amplification Technology Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Isothermal Nucleic Acid Amplification Technology Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type
  • Instruments
  • Reagents
By Applications
  • Infectious Diseases Diagnostics*
  • Blood Screening
  • Cancer Research
  • Others
By Technology
  • Nucleic Acid Sequence-based Amplification (NASBA)
  • Single Primer Isothermal Amplification (SPIA)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Helicase-dependent Amplification (HDA)
  • Transcription Mediated Amplification (TMA)
  • Loop-mediated Isothermal Amplification (LAMP)
  • Strand Displacement Amplification (SDA)
  • Others
By End User
  • Hospitals and Clinics
  • Diagnostic Center
  • Research Laboratories
  • Others
Regional Analysis for Isothermal Nucleic Acid Amplification Technology Market:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global Isothermal Nucleic Acid Amplification Technology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product Type
3.2. Snippet by Applications
3.3. Snippet by Technology
3.4. Snippet by End User

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
    4.1.1.2. Market Developments
  4.1.2. Restraints
    4.1.2.1. Growing Trend of Using Refurbished Equipment
  4.1.3. Opportunity
  4.1.4. Government Initiatives
  4.1.5. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. PEST Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID-19
  6.1.2. Scenario During COVID-19
  6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion

7. RUSSIA-UKRAINE WAR ANALYSIS

8. GLOBAL RECESSION ANALYSIS

9. ARTIFICIAL INTELLIGENCE IMPACT ANALYSIS

10. BY PRODUCT TYPE

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.1.2. Market Attractiveness Index, By Product Type
10.2. Instruments
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Reagents

11. BY APPLICATIONS

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
  11.1.2. Market Attractiveness Index, By Applications
11.2. Infectious Diseases Diagnostics*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Blood Screening
11.4. Cancer Research
11.5. Others

12. BY TECHNOLOGY

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.1.2. Market Attractiveness Index, By Technology
12.2. Nucleic Acid Sequence-based Amplification (NASBA)
  12.2.1. Introduction
  12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Single Primer Isothermal Amplification (SPIA)
12.4. Nicking Enzyme Amplification Reaction (NEAR)
12.5. Helicase-dependent Amplification (HDA)
12.6. Transcription Mediated Amplification (TMA)
12.7. Loop-mediated Isothermal Amplification (LAMP)
12.8. Strand Displacement Amplification (SDA)
12.9. Others

13. BY END USER

13.1. Introduction
  13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  13.1.2. Market Attractiveness Index, By End User
13.2. Hospitals and Clinics
  13.2.1. Introduction
  13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3. Diagnostic Center
13.4. Research Laboratories
13.5. Others

14. BY REGION

14.1. Introduction
  14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  14.1.2. Market Attractiveness Index, By Region
14.2. North America
  14.2.1. Introduction
  14.2.2. Key Region-Specific Dynamics
  14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
  14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.2.7.1. The U.S.
    14.2.7.2. Canada
    14.2.7.3. Mexico
14.3. Europe
  14.3.1. Introduction
  14.3.2. Key Region-Specific Dynamics
  14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
  14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.3.7.1. Germany
    14.3.7.2. The U.K.
    14.3.7.3. France
    14.3.7.4. Italy
    14.3.7.5. Spain
    14.3.7.6. Rest of Europe
14.4. South America
  14.4.1. Introduction
  14.4.2. Key Region-Specific Dynamics
  14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
  14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.4.7.1. Brazil
    14.4.7.2. Argentina
    14.4.7.3. Rest of South America
14.5. Asia-Pacific
  14.5.1. Introduction
  14.5.2. Key Region-Specific Dynamics
  14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
  14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.5.7.1. China
    14.5.7.2. India
    14.5.7.3. Japan
    14.5.7.4. Australia
    14.5.7.5. Rest of Asia-Pacific
14.6. Middle East and Africa
  14.6.1. Introduction
  14.6.2. Key Region-Specific Dynamics
  14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
  14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

15. COMPETITIVE LANDSCAPE

15.1. Competitive Scenario
15.2. Market Share Analysis
15.3. Mergers and Acquisitions Analysis

16. COMPANY PROFILES

16.1. Thermo Fisher Scientific Inc.
  16.1.1. Company Overview
  16.1.2. Product Type Portfolio and Description
  16.1.3. Financial Overview
  16.1.4. Key Developments
16.2. bioMerieux
16.3. Becton, Dickinson & Company
16.4. Lucigen
16.5. Qiagen
16.6. Quidel Corporation
16.7. Eiken Chemical Co. Ltd
16.8. Tecan Genomics Inc.
16.9. Meridian Bioscience
16.10. OptiGene Limited(*LIST NOT EXHAUSTIVE)

17. APPENDIX

17.1. About Us and Services
17.2. Contact Us


More Publications